New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 27, 2013
08:35 EDTAUXLAuxilium risk/reward remains favorable, says UBS
UBS continues to views Auxilium risk/reward favorable based on its growing business and potential for further indications for Xiaflex and business development. Shares are Buy rated with a $52 price target, up from $50.
News For AUXL From The Last 14 Days
Check below for free stories on AUXL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 14, 2014
08:16 EDTAUXLAuxilium management to meet with UBS
Subscribe for More Information
April 11, 2014
07:06 EDTAUXLVIVUS announces avanafil clinical data presentation
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use